Vitamin D for infections

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 21, Issue 6, 2014, Pages 431-436

  Korf, Hannelie ^a   Decallonne, Brigitte ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Immune; Infection; Macrophage; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D; 25-HYDROXYVITAMIN D; CALCITRIOL RECEPTOR; VITAMIN;

ADAPTIVE IMMUNITY; DRUG MECHANISM; DRUG METABOLISM; HUMAN; IMMUNOCOMPETENT CELL; INFECTION; INNATE IMMUNITY; REVIEW; ANALOGS AND DERIVATIVES; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; COMPLICATION; DEFICIENCY; DRUG EFFECTS; IMMUNOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VITAMIN D DEFICIENCY;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASES; CALCITRIOL; COMMUNICABLE DISEASES; HUMANS; IMMUNITY, INNATE; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84928947053     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000108     Document Type: Review

References (59)

1. Baeke F, Takiishi T, Korf H, et al. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010;10:482-496.
2. Hansdottir S, Monick MM, Hinde SL, et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008;181:7090-7099.
3. Overbergh L, Decallonne B, Valckx D, et al. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 2000;120:139-146.
4. Overbergh L, Stoffels K, Waer M, et al. Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J Clin Endocrinol Metab 2006;91:3566-3574.
5. Stoffels K, Overbergh L, Giulietti A, et al. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 2006;21:37-47.
6. Veldman CM, Cantorna MT, De Luca HF. Expression of 1, 25-dihydroxyvitamin D (3) receptor in the immune system. Arch Biochem Biophys 2000;374:334-338.
7. Finklea JD, Grossmann RE, Tangpricha V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr 2011;2:244-253.
8. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006;92:49-59.
9. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab 2005;16:261-266.
10. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773.
11. Grant WB. Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr Infect Dis J 2008;27:853.
12. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol 2009;158:20-25.
13. Danai PA, Sinha S, Moss M, et al. Seasonal variation in the epidemiology of sepsis. Crit Care Med 2007;35:410-415.
14. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006;134:1129-1140.
15. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-2072.
16. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.
17. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8-F28.
18. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
19. Krutzik SR, Hewison M, Liu PT, et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 2008;181:7115-7120.
20. Chen Y, Liu W, Sun T, et al. 1, 25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol 2013;190:3687-3695. This study links the novel microRNA system to vitamin D biology in the immune system.
21. Adams JS, Ren S, Liu PT, et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009;182:4289-4295.
22. Ren S, Nguyen L, Wu S, et al. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1, 25-dihydroxyvitamin D synthesis. J Biol Chem 2005;280:20604-20611.
23. Roth DE, Jones AB, Prosser C, et al. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J Infect Dis 2008;197:676-680.
24. Andraos C, Koorsen G, Knight JC, et al. Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. Hum Immunol 2011;72:262-268.
25. Chocano-Bedoya P, Ronnenberg AG. Vitamin D and tuberculosis. Nutr Rev 2009;67:289-293.
26. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180-188.
27. Wang TT, Nestel FP, Bourdeau V. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173:2909-2912.
28. Martineau AR, Wilkinson KA, Newton SM. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007;178:7190-7198.
29. Gombart AF, O'Kelly J, Saito T. Regulation of the CAMP gene by 1, 25 (OH) 2D3 in various tissues. J Steroid Biochem Mol Biol 2007;103:552-557.
30. Yim S, Dhawan P, Ragunath C. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1, 25-dihydroxyvitamin D (3). J Cyst Fibros 2007;6:403-410.
31. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011;7:337-345.
32. Romero R, Espinoza J, Goncalves LF. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21-39.
33. Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol Med 2007;13:117-124.
34. Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new antiinfective therapeutic strategies. Nat Biotechnol 2006;24:1551-1557.
35. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006;19:491-511.
36. Proud D, Sanders SP, Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol 2004;172:4637-4645.
37. Bergman P, Walter-Jallow L, Broliden K. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 2007;5:410-415.
38. Wang TT, Dabbas B, Laperriere D, et al. Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 2010;285:2227-2231.
39. Poon IK, Lucas CD, Rossi AG, et al. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 2014;14:166-180.
40. Sly LM, Lopez M, Nauseef WM, Reiner NE. 1alpha, 25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 2001;276:35482-35493.
41. Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009;6:231-243.
42. Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010;35:1039-1047.
43. Ferreira GB, Gysemans CA, Demengeot J, et al. 1, 25-dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. J Immunol 2014;192:4210-4220. Very detailed elaboration on the mechanisms underlying the tolerogenic capacity of vitamin D in dendritic cells in mice. Importantly, the study links in-vitro data to invivo findings.
44. Korf H, Wenes M, Stijlemans B, et al. 1, 25-dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 2012;217:1292-1300.
45. Ustianowski A, Shaffer R, Collin S, et al. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005;50:432-437.
46. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176:208-213.
47. Wejse C, Gomes VF, Rabna P, et al. Vitamin Dassupplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009;179:843-850.
48. Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008;87:688-691.
49. Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 2010;104:1487-1491.
50. Martineau AR. Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet 2012;379:1373-1375.
51. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006;38:3-5.
52. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D (3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a doubleblind randomised controlled trial. Lancet 2011;377:242-250.
53. Brook I. Microbiology and antimicrobial management of sinusitis. J Laryngol Otol 2005;119:251-258.
54. Montone KT. Infectious diseases of the head and neck: a review. Am J Clin Pathol 2007;128:35-67.
55. Wolf J, Daley AJ. Microbiological aspects of bacterial lower respiratory tract illness in children: atypical pathogens. Paediatr Respir Rev 2007;8:212-219.
56. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65:215-220.
57. Janssens W, Decramer M, Mathieu C, Korf H. Vitamin D and chronic obstructive pulmonary disease: hype or reality? Lancet Respir Med 2013;1:804-812. Critical and detailed review on a possible role for vitamin D in the treatment of COPD.
58. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012;156:105-114.
59. Durup D, Jorgensen HL, Christensen J, et al. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab 2012;97:2644-2652.